Trimetazidine

BH3 interacting domain death agonist ; Homo sapiens







1 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30771737 A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics. 2019 Apr 1